S&P 500

5.460,48

-0,41%

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

ANOR

Anormed Ord (MM) (ANOR)

Anormed Ord (MM)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANOR

1

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
07/11/2006	22h57	PR Newswire (US)	Genzyme Completes Tender Offer for Outstanding Shares of AnorMED	NASDAQ:ANOR
07/11/2006	06h01	PR Newswire (US)	Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review	NASDAQ:ANOR
03/11/2006	06h05	PR Newswire (US)	AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events	NASDAQ:ANOR
03/11/2006	06h05	PR Newswire (US)	AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events	NASDAQ:ANOR
26/10/2006	16h00	PR Newswire (US)	Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer	NASDAQ:ANOR	Anormed Ord (MM)
23/10/2006	16h00	PR Newswire (US)	AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule	NASDAQ:ANOR
17/10/2006	16h47	PR Newswire (US)	AnorMED and Genzyme reach agreement on acquisition	NASDAQ:ANOR
12/10/2006	04h03	PR Newswire (US)	AnorMED has determined Genzyme's offer is a 'superior proposal'	NASDAQ:ANOR
12/10/2006	03h47	PR Newswire (US)	AnorMED has determined Genzyme's offer is a 'superior proposal'	NASDAQ:ANOR
11/10/2006	06h30	PR Newswire (US)	AnorMED announces receipt of proposal from Genzyme Corporation	NASDAQ:ANOR
11/10/2006	06h30	PR Newswire (US)	AnorMED announces receipt of proposal from Genzyme Corporation	NASDAQ:ANOR
10/10/2006	16h50	PR Newswire (US)	Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash	NASDAQ:ANOR
06/10/2006	18h41	PR Newswire (US)	Genzyme Extends Deadline for Tender Offer to Acquire AnorMED Inc.	NASDAQ:ANOR	Anormed Ord (MM)
06/10/2006	05h10	PR Newswire (US)	AnorMED Board recommends shareholders accept Millennium offer	NASDAQ:ANOR
06/10/2006	05h10	PR Newswire (US)	AnorMED Board recommends shareholders accept Millennium offer	NASDAQ:ANOR
05/10/2006	06h36	PR Newswire (US)	AnorMED board continues to recommend that shareholders accept Millennium's planned tender offer	NASDAQ:ANOR
26/09/2006	16h46	PR Newswire (US)	Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date	NASDAQ:ANOR
26/09/2006	16h45	PR Newswire (US)	AnorMED agrees to support a planned tender offer of US$12 per share from Millennium Pharmaceuticals	NASDAQ:ANOR
25/09/2006	07h23	PR Newswire (US)	Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED	NASDAQ:ANOR
20/09/2006	16h00	PR Newswire (US)	AnorMED reports on Annual General Meeting	NASDAQ:ANOR
19/09/2006	14h30	PR Newswire (US)	AnorMED amends license agreement for cancer drug	NASDAQ:ANOR
19/09/2006	14h30	PR Newswire (US)	Poniard Pharmaceuticals Expands Picoplatin Agreement to Include Exclusive Worldwide Rights and Improved Financial Terms and Cond	NASDAQ:ANOR
18/09/2006	16h00	PR Newswire (US)	Approval of FOSRENOL in Germany triggers U.S.$3 million payment to AnorMED	NASDAQ:ANOR
16/09/2006	03h22	PR Newswire (US)	AnorMED Provides Update on Limited Duration Shareholder Rights Plan	NASDAQ:ANOR
12/09/2006	19h57	PR Newswire (US)	Atticus Capital LP Opposes Genzyme bid for AnorMED	NASDAQ:ANOR